Medicare to Negotiate Lower Prices for Weight-Loss Drugs

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans. Prices (Fares, Fees and Rates), GLP-1 RAs (Drug), Novo Nordisk A/S, Health Insurance and Managed Care, Drugs (Pharmaceuticals), Medicare, Obesity, Weight, Ozempic (Drug), United States Politics and Government, Health and Human Services Department, your-feed-healthcare, Biden, Joseph R Jr, Trump, Donald J NYT > Health

​The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans. 

Leave a Reply

Your email address will not be published. Required fields are marked *